IEEE PulsePub Date : 2026-05-01DOI: 10.1109/MPULS.2026.3700213
Chad Andresen
{"title":"Industry Corner Live With STIMIT CEO Ronja Mueller.","authors":"Chad Andresen","doi":"10.1109/MPULS.2026.3700213","DOIUrl":"https://doi.org/10.1109/MPULS.2026.3700213","url":null,"abstract":"<p><p>In this IEEE Pulse Industry Corner Live interview, Editor-in-Chief Chad Andresen speaks with Ronja Muller-Bruhn, CEO and Founder of STIMIT, about the company's non-invasive transcutaneous magnetic phrenic nerve stimulation system for ICU patients. Surface coils applied to the neck activate the diaphragm in sedated or comatose patients, targeting prevention of ventilator-induced diaphragm dysfunction-a condition causing up to 50% loss of respiratory muscle function within days of mechanical ventilation onset. With Health Canada clearance secured and a U.S. FDA De Novo pivotal trial underway, STIMIT aims to fundamentally shift ICU ventilation paradigms toward active preservation of natural respiratory neuromuscular physiology.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"17 3","pages":"40-44"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148680604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
IEEE PulsePub Date : 2026-05-01DOI: 10.1109/MPULS.2026.3700230
Jim Banks
{"title":"The U.K.'s Radical Shift in Allergy Treatment Could Save Lives.","authors":"Jim Banks","doi":"10.1109/MPULS.2026.3700230","DOIUrl":"https://doi.org/10.1109/MPULS.2026.3700230","url":null,"abstract":"<p><p>Allergies can rule a person's life, but fortunately advice on how to prevent and manage them is always evolving, in no small part due to groundbreaking research from the U.K. Jim Banks looks at the U.K.'s new National Allergy Strategy and why some of the leading experts behind it are calling for a paradigm shift in the cultural awareness of allergy risk.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"17 3","pages":"2-5"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148680683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
IEEE PulsePub Date : 2026-05-01DOI: 10.1109/MPULS.2026.3700223
Kristina Grifantini
{"title":"Minimally Invasive Ablation \"Zapping\" Therapies for COPD: Cells, Nerves, and New Possibilities.","authors":"Kristina Grifantini","doi":"10.1109/MPULS.2026.3700223","DOIUrl":"https://doi.org/10.1109/MPULS.2026.3700223","url":null,"abstract":"<p><p>Chronic obstructive pulmonary disease inhibits breathing through chronic inflammation, excessive mucus buildup, and destruction of lung tissue. Current treatments cannot reverse the disease. Scientists are using minimally invasive ablation therapies that target cells and nerves to offer promising new avenues to improve respiratory function.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"17 3","pages":"13-15"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148680538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
IEEE PulsePub Date : 2026-05-01DOI: 10.1109/MPULS.2026.3700224
Mahsa Ranji, Javad Hashemi, Myeongsub Kim, Stella Batalama
{"title":"Florida Atlantic University's New Department of Biomedical Engineering: Educating the Next Generation of Health Innovators.","authors":"Mahsa Ranji, Javad Hashemi, Myeongsub Kim, Stella Batalama","doi":"10.1109/MPULS.2026.3700224","DOIUrl":"https://doi.org/10.1109/MPULS.2026.3700224","url":null,"abstract":"<p><p>Florida Atlantic University has established a new Department of Biomedical Engineering (BME) to educate a diverse workforce at the intersection of engineering, medicine, biology, and artificial intelligence. This article introduces the department's educational vision, curriculum, and state-of-the-art laboratories designed to support experiential learning and clinical translation. By embedding AI throughout undergraduate and graduate tracks, the program provides students with practical, cross-disciplinary research opportunities. Additionally, the article highlights the department's primary research centers, illustrating how active collaborations among engineering, medicine, and industry advance biomedical discovery and healthcare technologies to address emerging global health challenges.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"17 3","pages":"56-63"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148680574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
IEEE PulsePub Date : 2026-05-01DOI: 10.1109/MPULS.2026.3700210
Leslie Mertz
{"title":"AI-Enabled Headband Uses Personalized Vibration to Ease Sinus Congestion.","authors":"Leslie Mertz","doi":"10.1109/MPULS.2026.3700210","DOIUrl":"https://doi.org/10.1109/MPULS.2026.3700210","url":null,"abstract":"<p><p>A vibrating headband, called SONU, and developed by the startup SoundHealth, applies personalized acoustic resonance therapy to treat symptoms of rhinitis. In late 2025, the company rolled out a separate headband to promote sleep.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"17 3","pages":"6-12"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148680580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
IEEE PulsePub Date : 2026-05-01DOI: 10.1109/MPULS.2026.3700102
Tejas Padliya
{"title":"Beyond the Inhaler: How Biologics, Phenotyping, and the Pursuit of Remission Are Redefining Airway Disease.","authors":"Tejas Padliya","doi":"10.1109/MPULS.2026.3700102","DOIUrl":"https://doi.org/10.1109/MPULS.2026.3700102","url":null,"abstract":"<p><p>Airway disease management is undergoing a structural transformation. For decades, asthma was treated as a single condition with a stepwise escalation of inhaled therapies, an approach that left the most severe cases cycling through treatments misaligned with their underlying biology. Updated global guidelines from the Global Initiative for Asthma (GINA) and ARIA-EAACI have shifted the field toward precision, biomarker-guided care. Central to this shift is the formal recognition of clinical remission as an achievable treatment goal, with real-world registry data now reporting on-treatment remission rates of 22%-34% across severe asthma populations on biologics. The united airway concept, linking allergic rhinitis, chronic rhinosinusitis, and asthma through shared T2 mechanisms, is reinforced by new evidence but remains fragmented in clinical practice. Meanwhile, environmental pressures including climate-driven allergen changes and air pollution are widening the gap between scientific capability and patient access, particularly in low- and middle-income settings. This article proposes the airway integration readiness (AIR) framework as a conceptual tool for evaluating how effectively care systems connect phenotype-guided therapy, cross-specialty airway co-management, and longitudinal remission tracking. It synthesizes the current evidence base, tracing how asthma and allergic airway disease are being redefined from episodic symptom management toward integrated, remission-oriented care, and identifies the translational challenges that remain.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"17 3","pages":"34-39"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148680601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
IEEE PulsePub Date : 2026-05-01DOI: 10.1109/MPULS.2026.3700229
Nathan Allen-Zimmerer
{"title":"The Fundamental Nanoparticle Recalibration of the Allergic Mind.","authors":"Nathan Allen-Zimmerer","doi":"10.1109/MPULS.2026.3700229","DOIUrl":"10.1109/MPULS.2026.3700229","url":null,"abstract":"<p><p>Current allergy treatments manage symptoms but rarely address the underlying immune response. This article explores how nanoparticle and mRNA-based therapies could retrain the immune system to tolerate allergens safely and precisely. While early research shows promising results, significant clinical testing and development are still needed before these therapies reach patients.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"17 3","pages":"26-33"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148680696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
IEEE PulsePub Date : 2026-05-01DOI: 10.1109/MPULS.2026.3700225
Leslie Mertz
{"title":"2-D Endoscope Video Feed Becomes 3-D With NeRF-Enabled Surgical Tracking System.","authors":"Leslie Mertz","doi":"10.1109/MPULS.2026.3700225","DOIUrl":"https://doi.org/10.1109/MPULS.2026.3700225","url":null,"abstract":"<p><p>A surgical tracking system, called vision-integrated surgical tracking assistance (VISTA), is being developed to use neural radiance fields (NeRFs) to take the current pre-operative computed tomography (CT) scan and video from the surgeon's 2-D endoscope and generate a quickly updated, 3-D view of the sinus surgery field as the surgeon removes tissue. The goal is to make standard sinus surgery procedures more precise and effective, and reduce the need for follow-up surgeries.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"17 3","pages":"20-25"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148680595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
IEEE PulsePub Date : 2026-05-01DOI: 10.1109/MPULS.2026.3700211
Tejas Padliya
{"title":"Airway Disease in 2026: Precision Medicine Meets Environmental and Clinical Reality.","authors":"Tejas Padliya","doi":"10.1109/MPULS.2026.3700211","DOIUrl":"https://doi.org/10.1109/MPULS.2026.3700211","url":null,"abstract":"<p><p>The 2025-2026 conference season in respiratory and allergy medicine has surfaced signals that the field is shifting faster than many clinical systems can absorb. The agendas converge on themes that were peripheral a decade ago: precision phenotyping, remission as a treatment target, the united airway as a clinical organizing principle, metabolic-inflammatory crossover, and the environmental forces reshaping disease burden in real time. This article traces those signals through emerging conference data, updated guidelines from GINA and ARIA-EAACI, and the growing evidence that climate-driven pollen shifts and access disparities are widening the gap between what the science now offers and what patients receive. It extends the analysis to environmental burden, emerging therapeutic signals, and translational challenges that define airway disease, with attention to the engineering infrastructure, including health digital twins and cross-specialty decision support, needed to close the gap between scientific capability and patient care.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"17 3","pages":"16-19"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148680598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
IEEE PulsePub Date : 2026-03-01DOI: 10.1109/MPULS.2026.3677916
Jim Banks
{"title":"Extra Vascular-Implantable Cardiodefibrillators: The Best of Both Worlds.","authors":"Jim Banks","doi":"10.1109/MPULS.2026.3677916","DOIUrl":"10.1109/MPULS.2026.3677916","url":null,"abstract":"<p><p>Though their inventor's vision was at first met with intense skepticism, implantable cardioverter-defibrillators have gone through many iterations to become the standard treatment for ventricular tachyarrhythmias. More than 40 years later, the advent of extravascular devices-EV-ICDs-represents another huge step forward.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"17 2","pages":"43-45"},"PeriodicalIF":0.2,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148240540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}